Who owns the DECODE trademark?

The DECODE trademark is owned by Repertoire Immune Medicines, Inc..

What class is the DECODE trademark registered in?

The DECODE trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for DECODE?

The USPTO serial number for DECODE is 88855951.

What is the registration number for DECODE?

DECODE is registered under USPTO registration number 7739313.

Sealvo

Home Search: DECODEDECODE #88855951

Back

Updated Oct 26, 2026·10 searches this week

View on USPTO TSDR Find similar marks

DEC

USPTO Trademark Record

REGISTERED

DECODE

SN 88855951·Reg 7739313·Filed Apr 01, 2020

Owner Repertoire Immune Medicines, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

DECODE (Serial No. 88855951), Registration No. 7739313, is a registered US trademark filed on Apr 01, 2020 by Repertoire Immune Medicines, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: March 25, 2031

Mark Intelligence

DECODE (Reg. #7739313) is a registered US trademark that has been protecting its owner, Repertoire Immune Medicines, Inc., since 2020. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 4 opposition proceedings during prosecution.

FILED

Apr 01, 2020

SERIAL

88855951

REG#

7739313

REGISTERED

Mar 25, 2025

Filing Information

StatusREGISTERED

Filing DateApr 01, 2020

Serial Number88855951

Registration No.7739313

Registration DateMar 25, 2025

Status DateMar 25, 2025

Published for OppositionDec 15, 2020

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1585125

480Oct 01, 2020

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Apr 22, 2024

First use in commerce: Apr 22, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

38 events

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 07, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 07, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 07, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 07, 2025

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 07, 2025

TEAS CHANGE OF OWNER ADDRESS RECEIVED

REGISTERED-PRINCIPAL REGISTER

Mar 25, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 25, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 03, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 03, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Feb 11, 2025

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 11, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Nov 27, 2024

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Nov 27, 2024

TEAS STATEMENT OF USE RECEIVED

SOU TEAS EXTENSION RECEIVED

May 24, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

May 24, 2024

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

May 24, 2024

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 29, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 FILED

Nov 27, 2023

SOU EXTENSION 1 FILED

SOU TEAS EXTENSION RECEIVED

Nov 27, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 GRANTED

Nov 27, 2023

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 30, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OPPOSITION DISMISSED NO. 999999

Apr 19, 2023

OPPOSITION DISMISSED NO. 999999

TTAB RELEASE CASE TO TRADEMARKS

Apr 19, 2023

TTAB RELEASE CASE TO TRADEMARKS

OPPOSITION TERMINATED NO. 999999

Apr 19, 2023

OPPOSITION TERMINATED NO. 999999

OPPOSITION INSTITUTED NO. 999999

Jun 14, 2021

OPPOSITION INSTITUTED NO. 999999

EXTENSION OF TIME TO OPPOSE RECEIVED

Jan 13, 2021

EXTENSION OF TIME TO OPPOSE RECEIVED

PUBLISHED FOR OPPOSITION

Dec 15, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 15, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 25, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 12, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 22, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 21, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 21, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Jun 28, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 28, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 28, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jun 22, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 08, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Repertoire Immune Medicines, Inc.

Additional USPTO filings from the same owner.

REP

REPERTOIRE IMMUNE MEDICINES

88774070

REPERTOIRE IMMUNE MEDICINES, INC.

REGISTERED

REP

REPERTOIRE

88774013

REPERTOIRE IMMUNE MEDICINES, INC.

REGISTERED

MCR

98478178

Repertoire Immune Medicines, Inc.

PENDING

TOR

TORCH

90877548

Repertoire Immune Medicines, Inc.

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

DEC

DECODE

99631999

Amrt Agro Inc

PENDING

DEC

DECODE

79183858

DECODE HQ d.o.o.

ABANDONED

DEC

DECODE TO RECODE

88411386

Dr. Elaine Chin

REGISTERED

PLA

PLATE DECODE

50166992

THINKING LAB WORKS LLC

PENDING

Other Marks by CHRISTINA M. LICURSI

Additional USPTO filings handled by the same attorney of record.

HER

HERO PIZZA

90749749

REGISTERED

97581845

REGISTERED

ENE

ENERGYKLIP

97886903

REGISTERED

XTR

XTREMEPASS

99363664

REGISTERED

DECODE

Run a conflict check

Other Marks by Repertoire Immune Medicines, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by CHRISTINA M. LICURSI

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company